98%
921
2 minutes
20
Selective embolization is the treatment of choice for traumatic renal pseudoaneurysm (PSA) in stable patients. N-Butyl-2-cyanoacrilate (NBCA) is an embolic agent frequently used to embolize peripheral lesions. N-Butyl-2-cyanoacrilate is one of the most widely used embolic materials because it is easy to prepare, it acts quickly and is highly cost-effective. Its use, however, requires a learning curve before becoming confident and being able to handle it safely. We describe a case of embolization of a renal traumatic PSA without clear pre-procedural CT-evidence of artero-calyx fistula in which the migration of NBCA in the renal pelvis occurred during the procedure. We report the successful multidisciplinary management of this complication.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321289 | PMC |
http://dx.doi.org/10.1093/bjrcr/uaaf039 | DOI Listing |
Diagn Microbiol Infect Dis
September 2025
Department of Infectious Diseases, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China. Electronic address:
This study describes the clinical characteristics and treatment of vertebral infection caused by Coxiella burnetii through a case report and literature review. We present a 60-year-old male with isolated lumbar vertebral infection. A comprehensive literature review identified 17 cases, with 82.
View Article and Find Full Text PDFJMIR Ment Health
September 2025
Department of Psychology, University of California, Los Angeles, 1285 Franz Hall, Box 951563, Los Angeles, CA, 90095, United States, 1 3107941262.
Background: Youth mental health issues have been recognized as a pressing crisis in the United States in recent years. Effective, evidence-based mental health research and interventions require access to integrated datasets that consolidate diverse and fragmented data sources. However, researchers face challenges due to the lack of centralized, publicly available datasets, limiting the potential for comprehensive analysis and data-driven decision-making.
View Article and Find Full Text PDFJMIR Hum Factors
September 2025
College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China.
Background: The rapid advancement of next-generation sequencing has significantly expanded the landscape of precision medicine. However, health care professionals face increasing challenges in keeping pace with the growing body of oncological knowledge and integrating it effectively into clinical workflows. Precision oncology decision support (PODS) tools aim to assist clinicians in navigating this complexity, yet their current functionalities only partially address clinical needs.
View Article and Find Full Text PDFRev Esc Enferm USP
September 2025
Universidade Federal do Triângulo Mineiro, Uberaba, MG, Brazil.
Objective: To evaluate the impact of an educational intervention on nursing care for women with signs of postpartum depression for primary health care nurses.
Method: Quasi-experimental, before-and-after study carried out with 14 primary health care nurses from a municipality, who participated in an educational intervention on nursing care for women with signs of postpartum depression. Qualitative data analysis was carried out before and after the intervention, using Bardin's thematic content analysis.
Med Sci (Paris)
September 2025
Département de cancérologie de l'enfant et l'adolescent (DCEA), Gustave Roussy cancer campus, Villejuif, France - Équipe mobile SPIAJA, équipe spécifique de prise en charge interdisciplinaire des adolescents et jeunes adultes, Gustave Roussy cancer campus, Villejuif, France.
Supporting the transition from pediatric to adult oncology presents challenges for all stakeholders, including adolescent and young adult (AYA) patients, their parents, pediatric oncologists, and medical oncologists. In this article, we describe the different stages of this transition and the transfer of care, the obstacles to the transition, and potential solutions. We discuss the contribution of AYA care in oncology through collaborations between pediatric and medical oncologists, and the importance of multidisciplinary support for patient empowerment.
View Article and Find Full Text PDF